Comments

LeMaitre Vascular

Q: What sector and industry does LeMaitre Vascular (LMAT) operate in?

LeMaitre Vascular is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

LMATNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$100.92

0.000.00%

Pre-Market: 4:00 PM EDT

Q4 2024 Earnings in 6 days from now on Thu Feb 27th, after the market close

Conference call scheduled in 6 days at 17:00 PM Click to view the webcast

LeMaitre Vascular (LMAT) Forecast

News Earnings LeMaitre Vascular (LMAT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Want to View Edge Rankings?

Unlock The Hidden Results With Your Benzinga Account Now.

Get Started

LeMaitre Vascular (NASDAQ:LMAT) Stock Quotes, Forecast and News Summary

LeMaitre Vascular Stock (NASDAQ: LMAT) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	21.00 / 172.92K
Day Range	- - -
52 Wk Range	59.87 - 109.58
Market Cap	$2.27B
P/E Ratio	55.45
Dividend Yield	0.63%
Exchange	NASDAQ
RSI	51
Short Interest	7.72%
Days to Cover	9.93

Recent News

Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday

Avi Kapoor

This Synopsys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

Acadia Healthcare Expands Behavioral Health Services in Iowa

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and Methodist Jennie Edmundson Hospital recently conducted a groundbreaking ceremony for a cutting-edge behavioral health hospital in Council Bluffs, IA.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Nov 24

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	21.00 / 172.92K
Day Range	- - -
52 Wk Range	59.87 - 109.58
Market Cap	$2.27B
P/E Ratio	55.45
Dividend Yield	0.63%
Exchange	NASDAQ
RSI	51
Short Interest	7.72%
Days to Cover	9.93

About Lemaitre Vascular Inc

Sector

Health Care

Industry

Health Care Equipment & Supplies

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral v...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy LeMaitre Vascular (LMAT) stock?

You can purchase shares of LeMaitre Vascular (NASDAQ:LMAT) through any online brokerage.

View our list of the best stock brokerages

Who are LeMaitre Vascular (LMAT) competitors?

Other companies in LeMaitre Vascular’s space includes: CeriBell (NASDAQ:CBLL), Axogen (NASDAQ:AXGN), Masimo (NASDAQ:MASI), Envista Holdings (NYSE:NVST) and Butterfly Network (NYSE:BFLY).

What is the forecast, or price target, for LeMaitre Vascular (LMAT) stock?

LeMaitre Vascular has a consensus price target of $88.22.

What is the current price for LeMaitre Vascular (LMAT)?

The stock price for LeMaitre Vascular (NASDAQ: LMAT) is $100.92 last updated February 20, 2025 at 4:00 PM EST.

Does LeMaitre Vascular (LMAT) pay a dividend?

A quarterly cash dividend of 0.16 per share of Class A Common Stock. The quarterly cash dividend was payable on December 5, 2024 to stockholders of record on November 21, 2024.

When is LeMaitre Vascular (NASDAQ:LMAT) reporting earnings?

LeMaitre Vascular’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is LeMaitre Vascular (LMAT) going to split?

There is no upcoming split for LeMaitre Vascular.

What sector and industry does LeMaitre Vascular (LMAT) operate in?

LeMaitre Vascular is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.